Page last updated: 2024-08-24

simendan and nicorandil

simendan has been researched along with nicorandil in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrosi, P; Andréjak, M; Gayet, JL1
Babelova, A; Brandes, RP; Buerkl, J; Hofstetter, C; Kirschning, T; Mieth, A; Neofitidou, S; Revermann, M; Schermuly, RT; Schloss, M; Schröder, K1

Reviews

1 review(s) available for simendan and nicorandil

ArticleYear
[The best of clinical pharmacology in 2002].
    Archives des maladies du coeur et des vaisseaux, 2003, Volume: 96 Spec No 1

    Topics: Anticholesteremic Agents; Antihypertensive Agents; Azetidines; Cardiovascular Diseases; Ezetimibe; Hormone Replacement Therapy; Humans; Hydrazones; Hypercholesterolemia; Losartan; Myocardial Infarction; Natriuretic Agents; Natriuretic Peptide, Brain; Neovascularization, Physiologic; Nicorandil; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Vasodilator Agents

2003

Trials

1 trial(s) available for simendan and nicorandil

ArticleYear
Levosimendan attenuates pulmonary vascular remodeling.
    Intensive care medicine, 2011, Volume: 37, Issue:8

    Topics: Airway Remodeling; Animals; Cardiotonic Agents; Disease Models, Animal; Germany; Glyburide; Hydrazones; Hypertension, Pulmonary; Hypoglycemic Agents; Myocardial Contraction; Nicorandil; Potassium Channels; Pulmonary Circulation; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Vasodilator Agents

2011